Our CEO, Joseph C. Sardano, talks to TWST about Sensus Healthcare’s corporate strategy, investment thesis and growth opportunities — and our superficial radiation therapy and Directional Anisotropic Radiation Therapy (ART) platforms.
Non Reoccurrence Rate
No anesthesia, cutting, bleeding, stitching or pain
No downtime or lifestyle restrictions
Super cosmesis, no unsightly scarring
No need for post-treatment reconstructive surgeries